3
Views
1
CrossRef citations to date
0
Altmetric
Letter To Editor

Letter To The Editor: “Efficacy and Tolerability of Divalproex Extended Release in Psychiatric Patients”

, , &
Pages 273-274 | Published online: 04 Dec 2011

References

  • Keck PE Jr., McElroy SL, Strakowski SM, Stanton SP, Kizer DL, Balistreri TM, Bennett JA, Tugrul KC, West SA: Factors associ-ated with pharmacologic noncompliance in patients with mania. J Clin Psychiatry 1996; 57:292–297
  • Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C: Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 2000; 61:549–555
  • Depakote ER Product Information. Abbott Laboratories, North Chicago, IL, c. 2000.
  • Home RL, Cunanan C: Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium. J Clin Psychopharmacol 2003; 23:176–181
  • Thibault M, Blume WT, Saint-Hilaire JM, Zakhari R, Sommerville KW: Divalproex extended-release versus the original divalproex tablet: Results of a randomized, crossover study of well-controlled epileptic patients with primary generalized seizures. Epilepsy Res 2002; 50:243–249

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.